Has COMET solved the controversy as to whether carvedilol is better than metoprolol in heart failure?

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.1, 2004-01, pp. : 205-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carvedilol Exerts More Potent Antiadrenergic Effect than Metoprolol in Heart Failure

By Kohno Takashi Yoshikawa Tsutomu Yoshizawa Akihiro Nakamura Iwao Anzai Toshihisa Satoh Toru Ogawa Satoshi

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 5, 2005-10 ,pp. : 347-355

Springer Publishing Company

Access to resources Recommend Favorite

Carvedilol ices metoprolol tartrate in chronic heart failure

Inpharma, Vol. 1, Iss. 1485, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Carvedilol less costly than metoprolol in patients with HF

Inpharma, Vol. 1, Iss. 1335, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Carvedilol in the treatment of chronic heart failure

By Moe G.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 831-843

Informa Healthcare

Access to resources Recommend Favorite

A Description of the Clinical Characteristics at Baseline of Patients Recruited into the Carvedilol or Metoprolol European Trial (COMET)

By Cleland John Goode Kevin Erhardt Leif Remme Willem Charlesworth Andrew Poole-Wilson Philip Di Lenarda Andrea Hanrath Peter Komajda Michel Metra Marco Swedberg Karl Torp-Pedersen Christian

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 2, 2004-03 ,pp. : 139-152

Springer Publishing Company

Access to resources Recommend Favorite